VivArt-X
PrivateLast Round
Grant
Feb 3, 2026
Total Funding Raised
$2.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VivArt-X is a medtech company that develops a platform technology for advanced tissue engineering, with a first product focused on a bio-absorbable scaffold for soft tissue regeneration after breast cancer surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VivArt-X Comparables
Compare VivArt-X with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healshape | 90% | |
| GenesisTissue Inc. | 85% | |
| Tensive | 84% | |
VivArt-X Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 3, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| Pre Seed | May 8, 2024 | ||||
| Grant | Dec 5, 2023 | ||||
| Pre Seed | Nov 20, 2023 |
VivArt-X Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metropoolregio Eindhoven | Grant |
| Brabantse Ontwikkelings Maatschappij | Pre Seed |
| Eindhoven University of Technology | Grant |
| TU/e Participations | Pre Seed |
| Maastricht University | Grant |
| Province of Noord-Brabant | Grant |
| Smart BioMaterials Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Received funding from Stimuleringsfonds Metropoolregio Eindhoven.
- Dec 1, 2025
Secured $3.24M from European Union and Dutch government.
VivArt-X Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VivArt-X's valuation, stock price, and market status.